澳洋健康 (002172.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

30.4x

Market Cap

CNY 3.40B

MomentumView details →

1D Return

+9.90%

YTD Return

+6.05%

RSI (14)

51.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

30.4x

Market Cap

CNY 3.40B

RSI (14)

51.7

MomentumView details →

1D Return

+9.90%

YTD Return

+6.05%

ProfitabilityView details →

Gross Margin

13.02%

Net Margin

1.59%

EBITDA Margin

6.86%

ROE (TTM)

15.47%

ROA (TTM)

1.61%

Asset Turnover

1.00x

GrowthView details →

Revenue YoY

−6.32%

EPS YoY

+18.98%

FCF YoY

+370.40%

Revenue CAGR 3Y

−3.67%

EPS CAGR 3Y

−8.71%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

4.31x

Current Ratio

0.59x

Quick Ratio

0.51x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.76B

Net Income (TTM)

28.03M

Op. CF (TTM)

224.40M

Latest newsMore news →

Aoyang Health announced its first-half results: revenue of 823 million yuan, down 8.89% year-on-year; net profit attributable to shareholders of 24.16 million yuan, down 23.42% year-on-year.19d ago

Similar companies

何氏眼科301103.SZ 普瑞眼科301239.SZ 皓宸医疗002622.SZ 光正眼科002524.SZ *ST美谷000615.SZ 盈康生命300143.SZ Find similar companies →

Latest newsMore news →

Aoyang Health announced its first-half results: revenue of 823 million yuan, down 8.89% year-on-year; net profit attributable to shareholders of 24.16 million yuan, down 23.42% year-on-year.19d ago